Is Ventas Inc (VTR) overvalued? · P/E 149, rev $4.92B
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
This page asks whether Ventas Inc (VTR) looks expensive on cached numbers — not a short thesis.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
VTR currently screens at market cap $39.94B and trailing P/E 149.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next VTR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the VTR stock page for the full model, not this heading.
Not investment advice.